荣旗科技：接受中信证券等投资者调研

Group 1 - Rongqi Technology (SZ 301360) announced an investor survey scheduled for October 23-24, 2025, with participation from key executives including the Vice President and CFO Wang Guijie [1] - For the year 2024, Rongqi Technology's revenue composition is entirely from high-end equipment manufacturing, accounting for 100% [1] Group 2 - As of the report, Rongqi Technology has a market capitalization of 4.4 billion yuan [2] - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a robust secondary market for biomedicine [2]